ProtAb Company

ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways.
Technology: Biologics (Ab)
Industry: Geroscience
Headquarters: Jerusalem, Yerushalayim, Israel
Founded Date: 2005-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: 4000000
Estimated Revenue: Less than $1M
Last Funding Date: 2010-04-23
Last Funding Type: Series A

Visit Website
http://www.hbl.co.il/portfolio_company.asp?ID=5
Register and Claim Ownership